Form 8-K vTv Therapeutics Inc. For: Mar 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
vTv Therapeutics (VTVT) Regains Nasdaq Compliance
March 26, 2024 4:37 PM EDTOn March 25, 2024, The Nasdaq Stock Market LLC (Nasdaq) notified vTv Therapeutics (NASDAQ: VTVT) that the Company had regained compliance with Nasdaq Listing Rule 5550(b)(2), which requires a listed company's market value of listed securities ("MVLS") to be at or above $35 million (the "MVLS Requirement").... More
